Nonalcoholic Fatty Liver Disease: Updates on Associations With the Metabolic Syndrome and Lipid Profile and Effects of Treatment With PPAR-γ Agonists
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2016.08.001
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Elsevier BV